US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Zolpidem Tartrate Tablets

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1247-2015
Class II · Moderate risk Terminated

Extended Phenytoin Sodium Capsules

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1246-2015
Class II · Moderate risk Terminated

Lamotrigine Extended-Release Tablets

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1245-2015
Class II · Moderate risk Terminated

Lisinopril Tablets USP

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1244-2015
Class II · Moderate risk Terminated

Amlodipine Besylate Tablets

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1243-2015
Class II · Moderate risk Terminated

Nifedipine Extended-Release Tablets

Reason Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point.

Valeant Pharmaceuticals North America LLC D-1116-2015
Class II · Moderate risk Terminated

Mucinex Fast Max DM Max

Reason Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.

Reckitt Benckiser LLC NDC 63824-019-66 D-1369-2015
Class II · Moderate risk Terminated

Fluoxetine Capsules USP

Reason Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.

Teva Pharmaceuticals USA NDC 50111-648-02 D-0971-2015
Class II · Moderate risk Terminated

Fluoxetine Capsules USP

Reason Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.

Teva Pharmaceuticals USA NDC 50111-647-01 D-0970-2015
Class II · Moderate risk Terminated

Hydroxyzine Hydrochloride

Reason Failed Impurities/Degradation Specifications

Akorn, Inc. NDC 50383-0796-16 D-1130-2015
Class II · Moderate risk Terminated

Hydroxyzine Hydrochloride

Reason Failed Impurities/Degradation Specifications

Akorn, Inc. NDC 10702-0052-16 D-1129-2015
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection

Reason Lack of Sterility Assurance: The product has the potential to leak at the administrative port.

Hospira Inc. D-0490-2015
Class II · Moderate risk Terminated

C-Topical 4% CII

Reason Labeling: Label mix-up; bottles were incorrectly labeled as 10 mL instead of correctly labeled as 4 mL

Cody Laboratories, Inc. NDC 0527-1728-74 D-0992-2015
Class II · Moderate risk Terminated

GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets

Reason Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.

Heritage Pharmaceuticals, Inc. D-0436-2015
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection

Reason Lack of Assurance of Sterility; increased complaints received for leaks

Baxter Healthcare Corp NDC 0338-0049-31 D-0429-2015
Class II · Moderate risk Terminated

Clinimix E 5/20 sulfite-free

Reason Lack of Assurance of Sterility; increased complaints received for leaks

Baxter Healthcare Corp NDC 0338-1125-04 D-0428-2015
Class II · Moderate risk Terminated

5% Dextrose Injection

Reason Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.

Baxter Healthcare Corp. NDC 0338-0017-04 D-0426-2015
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection

Reason Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.

Baxter Healthcare Corp. NDC 0338-0049-03 D-0425-2015
Class II · Moderate risk Terminated

Hydroxocobalamin 1) 1000mcg/mL

Reason Lack of assurance of sterility

Fallon Wellness Pharmacy, L.L.C. D-1075-2015